Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00618969 · ClinicalTrials.gov registry record · Phase 2
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors
A Phase 2 study, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT00618969 is a Phase 2 study that has completed, run by University of Arizona. The registered enrollment target is 2 participants.
The verdict
NCT00618969, a Phase 2 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to transplant haploidentical related peripheral blood stem cells (PBSCs) that come from a relative such as a parent, sibling, a child or other relative who has a half-matched tissue type with the recipient (rather than being completely matched) following administration of a reduced-intensity regimen of busulfan, melphalan and alemtuzumab.
Interventions
- OTHER haploidentical allogeneic PBSC transp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-02 |
| Est. Completion | 2016-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00618969
The ClinicalTrials.gov registry entry for NCT00618969 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which haploidentical allogeneic PBSC transp is the first listed.
NCT00618969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00618969 about?
NCT00618969 is a clinical study titled "Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors". The purpose of this study is to transplant haploidentical related peripheral blood stem cells (PBSCs) that come from a relative such as a parent, sibling, a child or other relative who has a half-matched tissue type with the recipient (rather than being completely matched) following administration o...
What is the current status of trial NCT00618969?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2008-02. Estimated completion is 2016-02.
What interventions are being tested in trial NCT00618969?
The interventions under investigation include: haploidentical allogeneic PBSC transp (OTHER).
Who is sponsoring clinical trial NCT00618969?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.